Gritstone bio, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Operating activities
Net Income Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Net amortization (accretion) of premiums and discounts on marketable securities
Amortization of debt discount and issuance costs
Stock-based compensation
Impairment of right-of-use assets
Non-cash operating lease expense
Loss on disposition of property and equipment
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Operating lease right-of-use assets
Deposits and other long-term assets
Accounts payable
Accrued compensation
Accrued and other non-current liabilities
Accrued research and development expenses
Deferred rent
Lease liability
Deferred revenue

Net cash used in operating activities
Investing activities
Purchase of marketable securities
Maturities of marketable securities
Sales of marketable securities
Purchase of property and equipment
Disposition of property and equipment
Prepayments on financing lease
Net cash provided by (used in) investing activities

Financing activities
Proceeds from issuance of common stock
Public Offering
PIPE Financing
Stock Options, Warrants and Other
ATM Equity Offering Program
ESPP Employee Stock Purchase Plan
Total proceeds from issuance of common stock

Proceeds from issuance of common stock and pre-funded warrants
Proceeds from long-term debt, net of debt discount and issuance costs
Payments of financing costs
Proceeds from issuance of convertible preferred stock, net of issuance costs
Payments of financing lease
Tax payments related to shares withheld for vested restricted stock units
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosures of non-cash investing and financing information
Property and equipment purchases accrued but not yet paid
Financing costs included in accrued liabilities and accounts payable
Remeasurement of operating lease right-of-use asset for lease modification
Receivable from lessor funded financing
Lease liabilities arising from obtaining right -of-use asset from new leases
Assets acquired under leasing obligations
Cash paid for interest on debt

Comments